Megan Staples

Mrs. Megan Staples

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2017 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
MSMegan Staples
Megan Staples
RGR. M. A. Graham
R. M. A. Graham
AJA. V. Jennison
A. V. Jennison
SUMMARY: Haemophilus influenzaeis an important aetiological organism of both adult and child respiratory disease. The number of non-typeable (NTHi) invasiveH. influenzaeisolates referred to the Queensland (QLD) Public Health Microbiology laboratory has increased notably year-by-year. In this study we used whole-genome sequencing to molecularly characterise 100 referred invasiveH. influenzae, including 74 NTHi isolates over a 15-year period, observing the carriage of capsular and putative virulence genes, including the major adhesins, antimicrobial resistance genes and population diversity. Encapsulated isolates were largely clonal, however NTHi isolates displayed high genetic variability by MLST and single nucleotide polymorphism typing with no dominant clone observed. The only mechanism forβ-lactam resistance identified in the QLD isolates wasβ-lactamase production. No single set of virulence determinants was conclusively associated with invasive QLD NTHi isolates.

1 February 2017 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
MSMegan Staples
Megan Staples
NFNing-Xia Fang
Ning-Xia Fang
RGRikki Marie Ann Graham
Rikki Marie Ann Graham
HSHelen V. Smith
Helen V. Smith
AJAmy V. Jennison
Amy V. Jennison

1 July 2017 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
MSMegan Staples
Megan Staples
RGR.M.A. Graham
R.M.A. Graham
VHV. Hicks
V. Hicks
JSJ. Strachan
J. Strachan
ASA. Gonçalves da Silva
A. Gonçalves da Silva
AJA.V. Jennison
A.V. Jennison

Verified
Journal Article
Open access
PDF file
ASAdam Sykes
Adam Sykes
SSSimon Smith
Simon Smith
HSHayley Stratton
Hayley Stratton
MSMegan Staples
Megan Staples
PRPatrick Rosengren
Patrick Rosengren
JHJosh Hanson
Josh Hanson
Lung involvement in patients with leptospirosis is associated with a more complicated disease course. However, the demographic and clinical associations of lung involvement are incompletely defined, and its optimal management is uncertain. This retrospective study examined consecutive patients admitted to a referral hospital in tropical Australia, with laboratory-confirmed leptospirosis between January 2015, and June 2024. Lung involvement was defined as new lung parenchymal changes on chest imaging at any point during the patients’ hospitalisation. The demographics, clinical findings and clinical course of the patients with and without lung involvement were compared. The median (interquartile range (IQR)) age of the 109 patients was 39 (24–56) years; 93/109 (85%) were male. Lung involvement was present in 62/109 (57%), 55 (89%) of whom had no documented comorbidities. Patients with lung involvement received antibiotics later in their disease course than those without lung involvement (after a median (IQR) of 5 (4–6) versus 3 (2–5) days of symptoms, p = 0.001). Lung involvement was frequently associated with multi-organ failure: patients with lung involvement were more likely to require intensive care unit admission than patients without lung involvement (41/62 (66%) versus 15/47 (32%), p < 0.001). Overall, 30/109 (28%) satisfied criteria for acute respiratory distress syndrome (ARDS) and 26/109 (24%) developed pulmonary haemorrhage. Patients with lung involvement received cautious fluid resuscitation, vasopressor support and prompt initiation of additional supportive care—including mechanical ventilation, renal replacement therapy and extracorporeal membranous oxygenation—guided by the patients’ physiological parameters and clinical trajectory. All 109 patients in the cohort were alive 90 days after discharge. Life-threatening lung involvement was identified in the majority of individuals in this cohort and occurred in young and otherwise well individuals. However, in Australia’s well-resourced health system excellent outcomes can be achieved using a standard contemporary approach to the management of a patient with undifferentiated infection while a confirmed diagnosis of leptospirosis is awaited.

30 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAdam Sykes
Adam Sykes
SSSimon Smith
Simon Smith
HSHayley Stratton
Hayley Stratton
MSMegan Staples
Megan Staples
PRPatrick Rosengren
Patrick Rosengren
JHJosh Hanson
Josh Hanson
Lung involvement in patients with leptospirosis is associated with a more complicated disease course. However, the demographic and clinical associations of lung involvement are incompletely defined, and its optimal management is uncertain. This retrospective study examined consecutive patients admitted to a referral hospital in tropical Australia, with laboratory-confirmed leptospirosis between January 2015, and June 2024. Lung involvement was defined as new lung parenchymal changes on chest imaging at any point during the patients’ hospitalisation. The demographics, clinical findings and clinical course of the patients with – and without – lung involvement were compared. The median (interquartile range (IQR)) age of the 109 patients was 39 (24-56) years; 93/109 (85%) were male. Lung involvement was present in 62/109 (57%), 55 (89%) of whom had no documented comorbidities. Patients with lung involvement re-ceived antibiotics later in their disease course than those without lung involvement (median (IQR): 5 (4-6) versus 3 (2-5) days of symptoms, p=0.001). Lung involvement was frequently just one component associated with multi-organ failure: patients with lung involvement were more likely to require inten-sive care unit admission than patients without lung involvement (41/62 (66%) versus 15/47 (32%), p< 0.001). Overall, 30/109 (28%) satisfied criteria for acute respiratory distress syndrome (ARDS) and 26/109 (24%) developed pulmonary haemorrhage. Patients with lung involvement received cautious fluid resuscitation, vasopressor support and prompt initiation of additional supportive care – including me-chanical ventilation, renal replacement therapy and extracorporeal membranous oxygenation – guided by the patients’ physiological parameters and clinical trajectory. All 109 patients in the cohort were alive 90 days after discharge. Life-threatening lung involvement can complicate leptospirosis in young and otherwise well individuals. However, in Australia’s well-resourced health system excellent outcomes can be achieved using a standard contemporary approach to the management of a patient with undif-ferentiated infection while a confirmed diagnosis of leptospirosis is awaited.

2 November 2026 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PRPatrick Rosengren
Patrick Rosengren
SSSimon Smith
Simon Smith
LJLiam Johnston
Liam Johnston
TCThomas Coombs
Thomas Coombs
NCNicholas Cairns
Nicholas Cairns
JHJosh Hanson
Josh Hanson
Objectives: In some resource‐limited settings the case‐fatality rate of severe leptospirosis can exceed 50%. Early recognition of severe disease can expedite transfer to referral centres for advanced supportive care. The entirely clinical, 3‐point SPiRO score can be calculated rapidly at presentation to predict a patient's subsequent clinical course. In its derivation study, a SPiRO score of 0 had a negative predictive value (NPV) for intensive care unit (ICU) admission of 98% (95% confidence interval [CI]: 96–99). In this validation cohort we sought to confirm the SPiRO score's prognostic utility and to compare its performance to other leptospirosis‐specific and general disease severity scores. Methods: We examined consecutive adults presenting to four high‐caseload hospitals in tropical Australia with laboratory‐confirmed leptospirosis between June 2016 and April 2026. The SPiRO score's ability to predict ICU admission before hospital discharge was compared with that of the leptospirosis‐specific QuickLepto score and commonly used disease severity scores, namely the SOFA, qSOFA, qSOFA‐lactate, NEWS‐2, qNEWS, UVA and the SIRS scores. Results: There were no deaths in 309 episodes of leptospirosis, but in 62 (20%) there was an ICU admission. The SPiRO score performed as well as, or better than, all the other scores in predicting ICU admission. The area under the receiver operating characteristic curve for the SPiRO score was 0.83 (95% CI: 0.77–0.89); only the SOFA score had a higher value: 0.84 (0.79–0.90), although the difference was not statistically significant ( p = 0.08). The SPiRO score had the highest NPV for ICU admission of any of the scores: 95 (95% CI: 91–97)%. Conclusions: The SPiRO score can be calculated easily at the bedside at presentation to expedite the recognition of patients with leptospirosis who are most likely to deteriorate. In resource‐limited settings this entirely clinical score can also help reduce unnecessary escalation of care, optimising the use of finite health resources.